drugset / Trial / NCT00868023

Next DPI LABA, Multicentre, 5-way Cross-over, Adult Asthmatic Patients

NCT00868023

Phase 2 Completed 69 enrolled Chiesi Farmaceutici S.p.A.
RandomizedCrossoverDouble-blindTreatment

Summary

Multinational, multicentre, randomised, double blind, double dummy, placebo and active controlled, 5-way cross over

Timeline

Start
2009-02
Primary completion
2009-07
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Formoterol Other / unclassified 6 ug Inhaled
Comparator Formoterol Other / unclassified 24 ug Inhaled
Comparator beclomethasone dipropionate Other / unclassified 100 ug Inhaled
Comparator beclomethasone dipropionate Other / unclassified 400 ug Inhaled

Indications